Fermented food and beverages

By optimizing the fermentation of soy milk with a specific sugar ratio, the product achieves enhanced NK cell activation and IL-12 production, addressing the need for immunostimulatory soybean milk yogurt.

JP2024158950AInactive Publication Date: 2024-11-08TOHOKU UNIV +1
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2023074607
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-04-28
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

There is a need for a soybean milk yogurt product with immunostimulatory effects, as existing products do not effectively activate NK cells and promote IL-12 production like those derived from cow's milk.

Method used

A fermented food or drink containing exopolysaccharides produced by Streptococcus thermophilus using a specific sugar ratio of glucose, lactose, raffinose, palatinose, and stachyose to sucrose, optimized for soy milk fermentation, enhances NK cell activation and IL-12 production.

Benefits of technology

The optimized soy milk fermentation process results in a product that significantly improves NK cell activity and IL-12 production, providing effective immunostimulation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024158950000001_ABST
    Figure 2024158950000001_ABST
Patent Text Reader

Abstract

To provide fermented beverages having an immunity activation effect through producing exopolysaccharide (EPS) and containing exopolysaccharide.SOLUTION: Fermented food and beverages contain exopolysaccharide (EPS) which is obtained through fermenting a base material including (A) at least one kind of saccharide selected from a group consisting of glucose, lactose, raffinose, palatinose, and stachyose and (B) sucrose at a weight ratio of (A):(B)=1:5 to 1:1 with exopolysaccharide (EPS) high productivity strain of lactic acid bacteria Streptococcus thermophilus.SELECTED DRAWING: Figure 1-1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a fermented food or drink. [Background technology]

[0002] It has been known that exopolysaccharides (EPS) are contained in fermented milk, including yogurt, which is produced by fermenting milk with lactic acid bacteria such as Lactobacillus delbrueckii ssp. bulgaricus (also known as Bulgarian bacteria) and Streptococcus thermophilus. In recent years, in response to the global spread of infectious diseases, consumers have become increasingly interested in improving their immunity, and it has been reported that the exopolysaccharides (EPS) produced by this lactic acid bacterium have immunostimulatory activity (Patent Document 1). In addition, it is known that exopolysaccharides (EPS) produced by the OLL1073R-1 strain, a type of Lactobacillus casei, have the effect of preventing autoimmune diseases, and fermented milk produced using the OLL1073R-1 strain has the effect of activating natural killer (NK) cells (hereinafter referred to as "NK activity") and reducing the incidence of colds. Furthermore, Patent Document 2 describes that exopolysaccharides (EPS) produced by Lactococcus lactis subsp. cremoris FC induces the production of interleukin-12 (hereinafter referred to as "IL-12"), which plays an important role in maintaining improved activity of the immune system. Among the various human immune indices, the one that evaluates NK activity is the most popular. Furthermore, the in vitro method of evaluating NK activity often uses IL-12 produced by macrophage-like cells as a marker. [Prior art documents] [Patent documents]

[0003] [Patent Document 1] Patent No. 5177728 [Patent Document 2] JP 2009-256312 A Summary of the Invention [Problem to be solved by the invention]

[0004] Milk yogurt containing exopolysaccharides (EPS) for the purpose of immune activation is already on the market. Demand for soy milk yogurt has been growing in recent years, but there is a demand for products with immune activation effects, but this has not yet been realized. We found that exopolysaccharides (EPS) obtained by fermenting soy milk activate NK cells more effectively than exopolysaccharides (EPS) obtained by fermenting cow's milk, and we investigated how to apply this result more efficiently. The researchers then compared the compositions of soy milk and cow's milk, focusing on stachyose, which is abundant in soy milk, to investigate the possibility of producing soy milk yogurt with immunostimulatory effects. [Means for solving the problem]

[0005] As a result of intensive research into solving the above problems, the present inventors have found that the above problems can be solved by adopting the following measures. 1. A fermented food or beverage containing exopolysaccharide (EPS) obtained by fermenting a base material containing one or more sugars from the group consisting of (A) glucose, lactose, raffinose, palatinose, and stachyose, and (B) sucrose in a weight ratio of (A):(B) = 1:5 to 1:1, using an exopolysaccharide (EPS)-rich strain of Streptococcus thermophilus. 2. The fermented food or drink described in 1., characterized in that the base material is soy milk. 3. A fermented food or beverage according to 1. or 2., characterized in that the weight ratio of the content of one or more of the sugars (A) in the substrate to the sucrose content (B) is (A):(B) = 1:5 to 1:1. 4. A fermentation substrate for an exopolysaccharide (EPS)-high producing strain of Streptococcus thermophilus, in which the weight ratio of the content of one or more sugars from the group consisting of (A) glucose, lactose, raffinose, palatinose, and stachyose to the content of (B) sucrose in the medium is adjusted to (A):(B) = 1:5 to 1:1. 5. A substrate having a weight ratio of (A) any one or more sugars from the group consisting of glucose, lactose, raffinose, palatinose, and stachyose to (B) sucrose, of (A):(B) = 1:5 to 1:1, A method for producing exopolysaccharides (EPS) with excellent immunostimulatory properties by fermentation using a high-EPS-producing strain of Streptococcus thermophilus. 6. The method for producing exopolysaccharide (EPS) according to 5., wherein the immunostimulation is achieved by improving NK activity and / or promoting IL-12 production. 7. A substrate having a content of one or more sugars from the group consisting of (A) glucose, lactose, raffinose, palatinose, and stachyose and a content of (B) sucrose in a ratio of (A):(B) = 1:5 to 1:1 by weight. A method for immunostimulation by administering exopolysaccharide (EPS) obtained by fermentation using an exopolysaccharide (EPS)-rich strain of Streptococcus thermophilus. 8. The method for immunostimulation described in 7, characterized in that the immunostimulation is achieved by improving NK activity and / or promoting IL-12 production. Effect of the Invention

[0006] According to the present invention, it is possible to achieve immunostimulation by using a food or drink obtained by fermenting soy milk. [Brief description of the drawings]

[0007] [Figure 1-1] 1 is a graph showing the amount of IL-12 produced in Example 1. [Figure 1-2] 1 is a graph showing the rate of improvement of NK activity in Example 1. [Figure 2-1] 1 is a graph showing the amount of IL-12 produced in Example 2. [Figure 2-2] 1 is a graph showing the improvement rate of NK activity in Example 2. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0008] The following description of the present invention does not limit the present invention. Any modifications or improvements to the following embodiments based on the ordinary knowledge of a person skilled in the art will also fall within the scope of the present invention, provided they do not deviate from the spirit of the present invention.

[0009] [(A) one or more sugars from the group consisting of glucose, lactose, raffinose, palatinose, and stachyose] (hereinafter sometimes referred to as "component A") The sugar that can be used as component A may be any of various isomers. The content of component A in the base material is preferably 3 to 10 g / L. [(B) Sucrose] (hereinafter sometimes referred to as "B component") The content of component B in the base material is preferably 5 to 15 g / L.

[0010] [Lactic acid bacteria] In the present invention, the lactic acid bacterium that performs fermentation is preferably Streptococcus thermophilus, which is a homofermentative lactic acid bacterium that produces lactic acid from sugar. In addition, two or more of Lactococcus lactis, Lactobacillus derbrueckii, Leuconostoc lactis, Lactobacillus fermentum, Lactobacillus brevis, etc. may be used in combination.

[0011] [Base material] In the present invention, the base material containing the above-mentioned components A and B is preferably soy milk. Any known soy milk can be used as such soy milk. In addition to soy milk, cow's milk, raw milk, goat's milk, sheep's milk, processed milk, milk with adjusted ingredients, milk that has been processed to reduce fat, etc. can be used alone or in combination. Although it is preferable to use soy milk alone, soy milk may be mixed with another milk. The soy milks include soy milk, prepared soy milk, and soy milk beverages. And "soy milk" which belongs to soy milks is defined in Article 2 of the Japanese Agricultural Standard for Soy Milks (Ministry of Agriculture, Forestry and Fisheries Notification No. 1679, July 17, 2012) as "a milky drink obtained by dissolving protein and other components from soybeans (excluding powdered soybeans and defatted soybeans) with hot water or other means and removing fiber, with a soybean solids content of 8% or more," and complies with the standard in Article 3. Furthermore, prepared soy milk and soy milk beverages which belong to soy milks are also defined in Article 2 of the Japanese Agricultural Standards, and comply with the standards in Articles 4 and 5, respectively. The soybean raw material may be at least one selected from soybeans and soybean processed products. Examples of soybean processed products include soy milk, ground and crushed soybeans, dehulled soybeans and ground and crushed soybeans, defatted soybeans, etc. It is preferable to use soy milk as the soybean raw material. However, soybean flour containing bean curd refuse may or may not be used as the soybean raw material. In addition, from the viewpoint of reducing the time required for lactic acid bacteria fermentation, enzyme-treated soy milk obtained by hydrolyzing soy milk in advance with a peptide bond hydrolase can be used as the soy milk. By using enzyme-treated soy milk, even when lactic acid bacteria with weak protease secretion (such as some strains of Lactobacillus brevis) are used, the fermentation can be promoted, the fermentation time can be shortened, and productivity can be improved.

[0012] The content of soybean solids in soymilks (strictly speaking, soybean solids derived from soymilks) is not particularly limited, but is, for example, 1.00 w / w% or more, 2.00 w / w% or more, 3.00 w / w% or more, 4.00 w / w% or more, 4.65 w / w% or more, and 15.00 w / w% or less, 10.00 w / w% or less, 8.00 w / w% or less, 5.00 w / w% or less.

[0013] [Exopolysaccharide (EPS)] Exopolysaccharides (EPS) is a general term for polysaccharides secreted and produced by microorganisms on the surface of their cells, and play a role in protecting the microorganisms from environmental stress. Exopolysaccharides (EPS) have a wide variety of structures depending on the type and number of sugars that make up the EPS and the bonding pattern, and are also used as food ingredients such as thickeners and stabilizers. Lactic acid bacteria are also known to produce EPS, which not only gives yogurt viscosity, but also has various physiologically active functions such as immunostimulating properties.

[0014] [Exopolysaccharide (EPS) high producing strain] In the present invention, the term "exopolysaccharide (EPS) high-producing strain" refers to a strain that produces 4 mg / L (culture scale) of exopolysaccharide (EPS). The measurement is carried out, for example, by the methods (1) to (8) of Example 1 below (sucrose in the medium is 5 g / L, and stachyose is 0 g / L).

[0015] [Fermented food and drink] Examples of the fermented food and drink of the present invention include soy milk yogurt and soy milk cheese. These foods and beverages may contain, or may not contain, sweeteners, high-intensity sweeteners, antioxidants, flavors, acidulants, salts, dietary fiber, proteins, edible oils and fats, thickeners, starches, gelling agents, pH adjusters, and the like (hereinafter referred to as "additives") that are usually blended as beverage ingredients or food ingredients, as long as the effects of the present invention are not impaired. Examples of sweeteners that can be used include high-fructose glucose liquid sugar, glucose, galactose, mannose, fructose, lactose, sucrose, and maltose. Examples of high-intensity sweeteners that can be used include neotame, acesulfame potassium, sucralose, saccharin, saccharin sodium, disodium glycyrrhizinate, cyclamate, dulcin, stevia, glycyrrhizin, thaumatin, monellin, aspartame, and alitame. Examples of antioxidants that can be used include vitamin C, vitamin E, and polyphenols. Examples of the acidulant that can be used include adipic acid, trisodium citrate, glucono delta lactone, gluconic acid, potassium gluconate, sodium gluconate, succinic acid, monosodium succinate, disodium succinate, sodium acetate, DL-tartaric acid, L-tartaric acid, sodium DL-tartrate, L-sodium tartrate, carbon dioxide, lactic acid, sodium lactate, acetic acid, fumaric acid, monosodium fumarate, DL-malic acid, sodium DL-malate, phosphoric acid, and phytic acid. Examples of the salts that can be used include table salt, potassium acid phosphate, calcium acid phosphate, ammonium phosphate, calcium sulfate, potassium metabisulfite, calcium chloride, potassium nitrate, and ammonium sulfate. Examples of the dietary fiber that can be used include resistant dextrin, pectin, polydextrose, and guar gum decomposition products. Examples of the protein that can be used include soy protein, wheat protein, corn protein, pea protein, casein, egg albumin, and gelatin. The edible oil and fat is not particularly limited as long as it is an edible oil and fat. As the thickener, for example, locust bean gum, guar gum, etc. can be used. As the starch, for example, modified starch, etc. can be used.As the gelling agent, pectin, carrageenan, etc. can be used. As the pH adjusting agent, for example, phosphates, etc. can be used. Furthermore, the above-mentioned food and drink can be used as desired in the form of gratin, cake, etc.

[0016] [Immune activation, NK activity improvement, IL-12 production promotion] In the present invention, the presence or absence of immunostimulation is expressed using the commonly used indicators of promotion of IL-12 production and improvement of NK activity. When a substrate is fermented with a certain lactic acid bacteria strain to produce exopolysaccharides (EPS), the exopolysaccharides (EPS) are added to macrophage-like cells to measure the amount of IL-12 produced, and the amount of IL-12 produced is measured if the amount of IL-12 produced by fermenting the substrate with stachyose (or other sugar) is 1.5 times higher than the amount of IL-12 produced by fermenting the medium without adding stachyose (or other sugar). This is defined as "IL-12 production is promoted" and "NK activity is improved." Furthermore, the exopolysaccharide (EPS) obtained by the present invention can be administered to a subject to stimulate the immune system. EXAMPLES

[0017] The present invention will be described below with reference to examples, but the technical scope of the present invention is not limited to these examples. <Example 1> Examination of the concentration of stachyose in the substrate The ratio of stachyose, a soybean oligosaccharide, to sucrose, a major component of soy milk, was varied using the method described below. The mixture was then mixed with DSM20617, a strain of Streptococcus thermophilus that produces exopolysaccharides (EPS). T The strain was fermented and exopolysaccharides (EPS) were isolated. The EPS was then applied to cells, and the NK activity was evaluated by measuring the amount of IL-12 in the cells. (1) Preparation of medium The media was mixed as described below, dissolved in pure water, and adjusted to pH 7.3. Tryptone 10g / L (ThermoFisherScientific) Yeast extract 5g / L (ThermoFisherScientific) Dipotassium hydrogen phosphate 2g / L (FUJIFILM Wako Pure Chemical Corporation) Sucrose 5 or 10g / L (FUJIFILM Wako Pure Chemical Corporation) Stachyose 0-10g / L (Tokyo Chemical Industry Co., Ltd.) Thereafter, the mixture was autoclaved at 121°C for 15 minutes, cooled in a cold room, and stored at 4°C. (2) Pre-culture of bacteria 5 mL of each medium was dispensed, 10 μL of lactic acid bacteria GS (glycerol stock) was added, and the mixture was pre-cultured at 37°C for 24 hours. (3) Main culture of bacteria The entire amount of the pre-cultured bacterial solution was added to the medium in which it had been stored, and the mixture was thoroughly stirred and cultured at 37°C for 24 hours. (4) Collection of culture medium and ethanol precipitation The culture medium was placed in a 500 mL centrifuge tube and centrifuged at 12,000 g for 20 minutes (MX-307, TOMY). The supernatant was collected and cooled at 4° C. An equal amount of chilled ethanol to the supernatant was added, mixed well, and allowed to stand at 4° C. (5) Re-ethanol precipitation The culture medium that had been left standing was centrifuged at 12,000 g for 10 minutes, the supernatant was discarded, and the precipitate was washed twice with 70% ethanol. The precipitate was then dissolved in 30 mL of pure water, and 30 mL of ethanol was added and the mixture was left standing at 4°C. (6) Enzyme treatment The sample was centrifuged at 12000g for 10 minutes, the supernatant was discarded, and the precipitate was washed twice with 70% ethanol. The precipitate was then dissolved in 30mL of pure water, and DNase (Deoxyribonuclease I from bovine pancreas, SIGMA-ALDRICH) and RNase (Ribonuclease A from bovine pancreas, SIGMA-ALDRICH) were added to 7μg / mL, and the mixture was incubated at 37℃ for 6 hours. ProteinaseK (ProteinaseK from Tritirachium album, SIGMA-ALDRICH) was then added to 200μg / mL, and the mixture was stirred well and incubated at 37℃ overnight. (7) Dialysis The sample was heated to 100° C. for 10 minutes to inactivate the enzyme, and then cooled to 4° C. Then, dialysis was performed using a MW8000 dialysis membrane (Spectra / Por (registered trademark), manufactured by REPLIGEN) for two days (the external solution was replaced after one day). (8) Freeze drying The internal liquid was collected and freeze-dried (FDU-2000, manufactured by EYELA), and the yield of the resulting exopolysaccharide (EPS) was measured (XSE105, manufactured by METLER TOLEDO). (9) Plate preparation, extracellular polysaccharide (EPS) addition J774.1 cells (mouse-derived macrophage-like cells, obtained from the JCRB Cell Bank) were plated in a 24-well plate (TRP) at a cell density of 3 × 10 5 The cells were seeded at 1000 cells / well. The medium used was DMEM medium (ThermoFisherScientific), 10% FBS (SIGMA-ALDRICH), and 1% Penicilin / Streptomycin (Nacalai Tesque). Each sample in (8) was adjusted to 2 mg / mL, vortexed (VOLTEX MIXER VTX-3000L, LMS), and then heated at 70°C for 10 minutes to sterilize and completely dissolve. Then, the sample was added to each well at a final concentration of 100 μg / mL, and cultured at 37°C for 48 hours. (10) Culture medium supernatant and cell recovery The culture supernatant (approximately 1 mL) was collected in a 1.5 mL tube (Eppendorf) and stored at 4°C. (11)ELISA analysis The amount of IL-12 in the samples was measured according to the protocol of the LBIS Mouse IL-12 ELISA Kit (Fujifilm Wako Shibayagi Co., Ltd.).

[0018] The results are shown in Figures 1-1 and 1-2. Figure 1-1 is a graph showing the amount of IL-12 produced. Figure 1-2 shows the amount of IL-12 produced expressed as a ratio to the amount produced without stachyose (0%), which is the improvement rate of NK activity. As shown in Figures 1-1 and 1-2, it was found that when the base material contains stachyose and sucrose in a weight ratio of 1:5 to 1:1, the production of IL-12 is promoted and NK activity is improved.

[0019] <Example 2> Examination of stachyose content in soy milk Next, by the method described below, the ratio of stachyose and sucralose was changed using soy milk as a base material, and the exopolysaccharide (EPS)-high producing strain of lactic acid bacteria Streptococcus thermophilus, DSM20617, was T The strain was fermented and exopolysaccharides (EPS) were isolated. The EPS was then applied to cells, and the NK activity was evaluated by measuring the amount of IL-12 in the cells. (1) Soy milk dialysis Soy milk (manufactured by Fuji Oil Co., Ltd.) was placed in a MW8000 dialysis membrane and dialyzed with 10 times the amount of external solution. One day after the start of dialysis, the external solution was replaced and dialysis was continued. Two days after the start of dialysis, the soy milk was collected and the water was removed using an evaporator, and the solid content was adjusted to be the same as that of the original soy milk. (2) Addition of sugar Sucrose was added to a concentration of 5 or 10 g / L, sterilized at 90°C for 10 minutes, and each soy milk was dispensed in 30 mL portions. (3) Fermentation test Lactic acid bacteria at a final concentration of 5 x 10 6The culture medium was then added at a concentration of 1.5 ml / mL and fermented at 37°C for 7 hours. (4) Extraction and ethanol precipitation of exopolysaccharides (EPS) The finished yogurt was homogenized, and 20 g portions were weighed out, 10 mL of 60% trichloroacetic acid was added, the mixture was thoroughly stirred, and the mixture was left to stand overnight at 4°C. The mixture was then centrifuged at 6000 g for 15 minutes. 12.5 mL of 20% trichloroacetic acid was added to 20 mL of the resulting supernatant, the mixture was thoroughly stirred, the mixture was left to stand in ice water for 1 hour, and the mixture was centrifuged at 6000 g for 15 minutes. 28 mL of ethanol was added to 12 mL of the supernatant, the mixture was thoroughly stirred, and the mixture was left to stand overnight at -30°C. (5) Washing and enzyme treatment After centrifugation at 8000g for 15 minutes, the supernatant was removed and the precipitate was washed twice with 70% ethanol. The precipitate was dissolved in 5 mL of pure water, and DNase and RNase were added to 7 μg / mL, followed by incubation at 37°C for 6 hours. Proteinase K was then added to 200 μg / mL, and the mixture was stirred well and incubated at 37°C overnight. (6) Thereafter, the amount of IL-12 in the sample was measured in the same manner as in Example 1(7) onwards.

[0020] The results are shown in Figures 2-1 and 2-2. Figure 2-1 is a graph showing the amount of IL-12 produced. Figure 2-2 shows the amount of IL-12 produced as a ratio to the amount produced without stachyose (0%), which is the improvement rate of NK activity. As shown in Figures 2-1 and 2-2, it was found that when stachyose and sucrose are contained in soy milk in a weight ratio of 1:5 to 1:1, the production of IL-12 is promoted and NK activity is improved.

[0021] <Example 3> Study of available lactic acid bacteria Next, the ratio of stachyose to sucrose in the fermentation medium was fixed at 1:2, and exopolysaccharides (EPS) were purified by fermenting the medium with various lactic acid bacteria, and the improvement rate of NK activity was examined. The following lactic acid bacteria were used: ·Streptococcus thermophilus JCM20026 strain ·Streptococcus thermophilus DSM20617 T KK ·Streptococcus thermophilus DSM8713 strain ·Streptococcus thermophilus ISO13957 strain ·Streptococcus thermophilus DSM20259 strain ·Streptococcus thermophilus DSM20479 strain ·Leuconostoc mesenteroides mesentroides JCM6124 strain ·Lactococcus lactis IFO12007 strain ·Lactococcus lactis lactis JCM5805 strain

[0022] (1) Preparation of medium The medium was mixed as shown below, dissolved in pure water, and adjusted to pH 7.3. (Two versions were prepared, one without stachyose and one with stachyose added at 5 g / L.) Tryptone 10g / L Yeast extract 5g / L Dipotassium hydrogen phosphate 2g / L Sucrose 10g / L Stachyose 0 or 5g / L Thereafter, the mixture was autoclaved at 121°C for 15 minutes, cooled in a cold room, and stored at 4°C. (2) The amount of IL-12 in the samples was then measured in the same manner as in (2) and subsequent steps of Example 1. The results are shown in Table 1. The amount of medium in the table refers to the amount of medium prepared in (1).

[0023] [Table 1] As shown in Table 1, Streptococcus thermophilus JCM20026 and Streptococcus thermophilus DSM20617, which are high-EPS producers, T When the strain was used, the NK activity was improved by more than 1.5 times, indicating that the immunostimulatory activity was improved. The Leuconostoc mesenteroides mesentroides JCM6124 strain, which is a high-production strain of exopolysaccharide (EPS) but is not a Streptococcus thermophilus species, did not show a high NK activity improvement rate.

[0024] <Example 4> Examination of available sugars Next, various sugars other than stachyose and sucrose were added to the fermentation medium at a fixed ratio of 1:2, and Streptococcus thermophilus DSM20617 was cultured. T The strain was fermented, exopolysaccharides (EPS) were purified, and the improvement rate of NK activity was examined to confirm the types of sugars that can be used in the present invention.

[0025] (1) Preparation of medium The media was mixed as described below, dissolved in pure water, and adjusted to pH 7.3. Tryptone 10g / L Yeast extract 5g / L Dipotassium hydrogen phosphate 2g / L Sucrose 10g / L ·Each sugar 5g / L Thereafter, the mixture was autoclaved at 121°C for 15 minutes, cooled in a cold room, and stored at 4°C.

[0026] (2) Thereafter, the amount of IL-12 in the sample was measured in the same manner as in Example 1(2) onwards. The results are shown in Table 2. The improvement rate of NK activity is a value calculated by taking the NK activity when the sugar source was sucrose alone as 1. The sugars used are as follows: Glucose: D(+)-glucose (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) Lactose: Lactose monohydrate (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) Mannose: D(+)-mannose (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) Fructose: D(-)-fructose (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) Galactose: D(+)-galactose (FUJIFILM Wako Pure Chemical Industries, Ltd.) Raffinose: D-(+)-raffinose pentahydrate (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) Allose: D-(+)-allose (manufactured by Tokyo Chemical Industry Co., Ltd.) Fructooligosaccharide: Fructooligosaccharide (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) Inulin: Inulin (Tokyo Chemical Industry Co., Ltd.) Inositol: myo-inositol (Tokyo Chemical Industry Co., Ltd.) Isomalto-oligosaccharide: Isomalto-oligosaccharide (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) Maltitol: Maltitol (Tokyo Chemical Industry Co., Ltd.) Palatinose: Palatinose hydrate (Tokyo Chemical Industry Co., Ltd.) Trehalose: Trehalose dihydrate (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) Xylitol: Xylitol (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) Xylobiose: Xylobiose (Tokyo Chemical Industry Co., Ltd.)

[0027] [Table 2]

[0028] Since the one that has a large rate of improvement in NK activity can be used in the present invention, it was confirmed that glucose, lactose, raffinose, and palatinose can also be used in addition to stachyose.

Claims

1. A fermented food or drink product contains exopolysaccharide (EPS) obtained by fermenting a substrate containing one or more sugars selected from the group consisting of (A) glucose, lactose, raffinose, palatinose, and stachyose, and (B) sucrose in a weight ratio of (A):(B) = 1:5 to 1:1, using an exopolysaccharide (EPS)-high producing strain of Streptococcus thermophilus.

2. The fermented food or drink according to claim 1 , wherein the base material is soy milk.

3. The fermented food or beverage according to claim 1 or 2, characterized in that the weight ratio of the content of one or more of the sugars (A) to the sucrose content (B) in the substrate is (A):(B) = 1:5 to 1:

1.

4. A fermentation substrate for an exopolysaccharide (EPS)-producing strain of Streptococcus thermophilus, the fermentation substrate being adjusted so that the weight ratio of the content of one or more sugars (A) from the group consisting of glucose, lactose, raffinose, palatinose, and stachyose to the content of sucrose (B) in a medium is (A):(B)=1:5 to 1:

1.

5. A substrate having a weight ratio of (A) any one or more sugars from the group consisting of glucose, lactose, raffinose, palatinose, and stachyose to (B) sucrose of (A):(B) = 1:5 to 1:1, A method for producing exopolysaccharides (EPS) having excellent immunostimulatory properties by fermentation using a high-EPS-producing strain of Streptococcus thermophilus.

6. 6. The method for producing exopolysaccharides (EPS) according to claim 5, wherein the immunostimulation is achieved by improving NK activity and / or promoting IL-12 production.

7. A substrate having a weight ratio of (A) any one or more sugars from the group consisting of glucose, lactose, raffinose, palatinose, and stachyose to (B) sucrose of (A):(B)=1:5 to 1:

1. A method for immunostimulation by administering exopolysaccharide (EPS) obtained by fermentation using an exopolysaccharide (EPS)-rich strain of Streptococcus thermophilus.

8. The immunostimulating method according to claim 7, wherein the immunostimulation is achieved by improving NK activity and / or promoting IL-12 production.

Citation Information

Patent Citations

  • Nainenkikanno tenkaseigyoshisutemu

    JP1976077728A

  • Immunomodulating composition and food and drink or material for food and drink using the composition

    JP2009256312A